THOMAS APPIO - 02 Mar 2022 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)

Role: CEO, Pharma Business
Signature: /s/ Debra E. Levin, attorney-in-fact for Thomas Appio
Issuer symbol: BHC
Transactions as of: 02 Mar 2022
Net transactions value: $0
Form type: 4
Filing time: 04 Mar 2022, 15:50:58 UTC
Previous filing: 02 Mar 2022
Next filing: 07 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BHC	Common Shares, No Par Value	Award	$0	+152,690	+47%	$0.000000	480,831	02 Mar 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BHC	Non-Qualified Stock Options (right to purchase)	Award	$0	+565,330		$0.000000	565,330	02 Mar 2022	Common Shares, No Par Value	565,330	$24.17	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc.
F2	The options vest in equal installments on each of the first three anniversaries of the date of grant.